Gongwin Biopharm Holdings Company is Pharmaceuticals in Taiwan that focus on Holdings Co Ltd business. Founded in 2014. They cover business area such as Gongwin Biopharm Holdings Co Ltd, research, development, anti-cancer drug, product, central lung serious tracheal obstruction, primary liver cancer, malignant pleural effusion, tracheal adenoid cystic carcinoma.
2014
( 10 years old in 2024 )
Holdings Co Ltd
-
3rd Floor, No. 80, Jianguo North Road
Zhongshan District
Taipei City, 104-91
Taiwan
Private
Gongwin Biopharm Holdings Co Ltdresearchdevelopmentanti-cancer drugproductcentral lung serious tracheal obstructionprimary liver cancermalignant pleural effusiontracheal adenoid cystic carcinoma
* We use standard office opening hours in near Gongwin Biopharm Holdings Company's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Gongwin Biopharm Holdings Company is Pharmaceuticals business from Taiwan that founded in 2014 (10 years old in 2024), Gongwin Biopharm Holdings Company business is focusing on Holdings Co Ltd.
Gongwin Biopharm Holdings Company headquarter office and corporate office address is located in 3rd Floor, No. 80, Jianguo North Road Zhongshan District Taipei City, 104-91 Taiwan.
Gongwin Biopharm Holdings Company was founded in Taiwan.
In 2024, Gongwin Biopharm Holdings Company is currently focus on Holdings Co Ltd sector.
Above is snippet of Google Trends for "Holdings Co Ltd" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Gongwin Biopharm Holdings Company, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
